RxSight Inc (RXST)
44.16
-0.49
(-1.10%)
USD |
NASDAQ |
Nov 14, 16:00
44.22
+0.06
(+0.14%)
After-Hours: 07:32
RxSight Cash and Short Term Investments (Quarterly): 237.12M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 237.12M |
June 30, 2024 | 233.28M |
March 31, 2024 | 125.35M |
December 31, 2023 | 127.18M |
September 30, 2023 | 131.88M |
June 30, 2023 | 147.09M |
March 31, 2023 | 153.94M |
December 31, 2022 | 105.80M |
Date | Value |
---|---|
September 30, 2022 | 112.84M |
June 30, 2022 | 128.62M |
March 31, 2022 | 143.85M |
December 31, 2021 | 159.33M |
September 30, 2021 | 168.26M |
June 30, 2021 | 61.73M |
March 31, 2021 | 64.38M |
December 31, 2020 | 68.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
61.73M
Minimum
Jun 2021
237.12M
Maximum
Sep 2024
135.60M
Average
130.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Tandem Diabetes Care Inc | 473.30M |
Perspective Therapeutics Inc | 292.87M |
Retractable Technologies Inc | 41.90M |
Xtant Medical Holdings Inc | 5.379M |
Catheter Precision Inc | 0.016M |